IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...

IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Are women somehow missing from the future of innovation? New research suggests that gender bias may be quietly shaping the ...

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...

HHS Secretary Robert F Kennedy Jr has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development.

Moderna announced July 10 that the FDA had fully approved its Spikevax COVID vaccine for kids ages 6 months through 11 years ...

The recent announcement of RFK Jr.’s termination of mRNA vaccine contracts is the latest effort to undermine this promising ...

Baillie Gifford's Q2 2025 portfolio grew to $134B, focusing on growth stocks like NVIDIA and MercadoLibre. Click here to read ...